BLAIRVACQ Jean François SRL
BLAIRVACQ Jean François reported total assets of 29,415 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Aug 2026).
The score of BLAIRVACQ Jean François shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
BLAIRVACQ Jean François's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Aug 2026
- Year ended 31 Dec 2024filed on 23 Jun 2025
BLAIRVACQ Jean François's financial analysis
- Solvency43.8%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of BLAIRVACQ Jean François
BLAIRVACQ Jean François's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1002.902.893
- VAT number
- BE1002902893
- Peppol
- Registered · 0208:1002902893 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 01 Dec 2023
- Registered office
- 4300 Waremme
- Latest accounts
- 2025 · filed on 28 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
BLAIRVACQ Jean François (SRL) has been based in Waremme since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 11,161 € and equity of 12,891 €; its revenue is not published. Its solvency stands at 43.8%, above the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to BLAIRVACQ Jean François
Companies in the same business, of comparable size and area, outside its group.
- Anne Longueville Retail sale of pharmaceutical products Écaussinnes · balance sheet 29,378 €
- Espace Medical Jumet Retail sale of pharmaceutical products Charleroi · balance sheet 29,613 €
- Deropharma Retail sale of pharmaceutical products Waterloo · balance sheet 29,143 €
- AB Society Retail sale of pharmaceutical products Saint-Ghislain · balance sheet 31,595 €
- Goed Aalter Retail sale of pharmaceutical products Anderlecht · balance sheet 31,881 €
- Lorena Boulanger Pharma Retail sale of pharmaceutical products Chapelle-lez-Herlaimont · balance sheet 32,165 €
- VENI Retail sale of pharmaceutical products Meise · balance sheet 32,367 €
- NL Pharma Retail sale of pharmaceutical products Florennes · balance sheet 33,758 €
Frequently asked questions about BLAIRVACQ Jean François
What is the revenue of BLAIRVACQ Jean François?
BLAIRVACQ Jean François files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of BLAIRVACQ Jean François?
In Belgium, the VAT number is the company number prefixed with BE: BE1002902893 for BLAIRVACQ Jean François, if the company is VAT-registered. Its company number (CBE) is 1002.902.893.
Where is the registered office of BLAIRVACQ Jean François?
According to the CBE register, the registered office of BLAIRVACQ Jean François is in 4300 Waremme.
What is the equity of BLAIRVACQ Jean François?
At the close of the 2025 financial year, the equity of BLAIRVACQ Jean François amounts to 12,891 €, a solvency of 43.8% of total assets.
Who manages BLAIRVACQ Jean François?
The register lists 1 active mandates at BLAIRVACQ Jean François. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of BLAIRVACQ Jean François
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →